NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-130-2001-0-AU-02 Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes AU National Stage 2002337885 Abandoned
NCI E-130-2001-0-PCT-01 Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes PCT PCT PCT/US02/33165 Abandoned
NCI E-046-1991-5-US-03 METHOD OF PREVENTING TUMOR METASTASIS (AS FILED) US CON 10/270,564 Abandoned
NCI E-130-2001-0-CA-04 Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus Selected By ENV-CD4-CO-Receptor Complexes CA National Stage 2463931 Abandoned
NCI E-297-2002-0-CA-03 Methods of Preparing Lymphocytes That Express Interleukin-2 and Their Use in the Treatment of Cancer CA National Stage 2501087 Abandoned
NCI E-297-2002-0-AU-04 Methods of Preparing Lymphocytes that Express Interleukin-2 and their Use in the Treatment of Cancer AU National Stage 2002353822 Abandoned
NCI E-297-2002-0-PCT-01 Methods of Preparing Lymphocytes that Express Interleukins-2 and Their Use in the Treatment of Cancer PCT PCT PCT/US2002/033243 Expired
NIA E-146-1993-0-US-10 METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT US CON 10/272,496 Abandoned
NCI E-297-2002-0-EP-05 Methods of Preparing Lymphocytes that Express Interleukins-2 and Their Use in the Treatment of Cancer EP National Stage 02789213.2 Abandoned
NIMH E-098-2001-1-US-01 Methods of Manipulating Nucleic Acids US CIP 10/269,515 Abandoned
NCI E-171-2000-0-JP-03 Highly Cross-Linked, Extremely Hydrophobic Nitric Oxide-Releaseing Polymers And Methods For Their Manufacture And Use JP ORD 2002-292578 Expired
NIDA E-057-2000-0-US-03 TREATMENT OF NEUROPSYCHIATRIC DISEASE WITH PROTEASE AND NEURAMINIDASE INHIBITORS US National Stage 10/182,162 Abandoned
NCI E-158-2001-0-PCT-01 Tandem Repeat Markers PCT PCT PCT/US02/031634 Expired
NIA E-138-2000-0-US-03 Tumor Markers in Ovarian Cancer US National Stage 10/257,021 7279294 Abandoned PDF
NIMH E-038-2007-3-PCT-02 Nucleic Acid Molecules, Polypeptides And Uses Therefor, Including Diagnosis And Treatment Of Alzheimer's Disease PCT PCT PCT/US02/31642 Expired
NIMH E-038-2007-4-US-01 Nucleic Acid Molecules, Polypeptides And Uses Therefor, Including Diagnosis And Treatment Of Alzheimer's Disease US CIP 10/264,309 Abandoned
NIMH E-038-2007-3-EP-03 Diagnosis and treatment of Alzheimer's disease EP ORD 02256893.5 Expired
NCI E-167-2007-0-RU-01 Antigenic Peptides RU ORD 20022126396 Abandoned
NCI E-148-1998-1-US-03 Molecular Clones With Mutated HIV GAG/POL,SIV GAG And SIV ENV Genes US CON 10/263,020 8076100 Expired PDF
NCI E-171-2000-0-EP-02 Highly Cross-Linked, Extremely Hydrophobic Nitric Oxide-Releaseing Polymers And Methods For Their Manufacture And Use EP National Stage 02256854.7 Expired
NCI E-262-1999-1-US-02 HGF-SF Monoclonal Antibody Combinations US National Stage 10/129,596 7459536 Expired PDF
NICHD E-069-2000-2-US-02 METHODS OF MAKING AND USING 7alpha, 11beta-DIMETHYL-17beta HYDROXYESTER-4-EN-3-ONE 17 Undecanoate US ORD 10/260,854 Abandoned
NCI E-075-2001-0-PCT-01 Methods and Compositions for Production and Purification of Recombinant Staphylococcal Enterotoxin B (rSEB) PCT PCT PCT/US2002/031114 Expired
NIAID E-092-2003-0-PCT-02 Paramyxoviruses As Gene Transfer Vectors To Lung Cells PCT PCT PCT/US02/30813 Expired
NIAID E-092-2003-0-EP-04 Paramyxoviruses As Gene Transfer Vectors To Lung Cells EP National Stage 02763762.8 Abandoned
NCI E-129-2001-0-CA-06 Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. CA National Stage 2461351 Expired
NCI E-129-2001-0-EP-04 Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. EP National Stage 02761818.0 Expired
NCI E-129-2001-0-IT-12 Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. IT EP 02761818.0 Expired
NCI E-129-2001-0-ES-09 Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. ES EP 02761818.0 Expired
NCI E-129-2001-0-GB-11 Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. GB EP 02761818.0 Expired
NCI E-129-2001-0-FR-10 Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. FR EP 02761818.0 Expired
NCI E-129-2001-0-DE-08 Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. DE EP 02761818.0 Expired
NCI E-129-2001-0-AU-05 Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. AU National Stage 2002327053 Expired
NCI E-347-2003-3-US-02 Composite Antibodies of Humanized Human Subgroup IV Light Chain Capable of Binding to Tag-72 US DIV 10/255,478 7179899 Expired PDF
NCI E-129-2001-0-PCT-02 Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. PCT PCT PCT/US2002/030316 Expired
NIAID E-241-2001-0-CA-13 Development of a Preventive Vaccine for Filovirus Infection in Primates CA DIV 2776272 Expired
NIAID E-241-2001-0-CA-11 Development of a Preventive Vaccine for Filovirus Infection in Primates CA DIV 2776391 Expired
NIAID E-241-2001-0-CA-12 Development of a Preventive Vaccine for Filovirus Infection in Primates CA DIV 2776522 Expired
NIAID E-241-2001-0-CA-04 Development of a Preventive Vaccine for Filovirus Infection in Primates CA National Stage 2462455 Expired
NIAID E-241-2001-1-CA-04 Development of a Preventive Vaccine for Filovirus Infection in Primates CA DIV 2519282 Expired
NIAID E-241-2001-1-JP-05 Development of a Preventive Vaccine for Filovirus Infection in Primates JP DIV 2005-280131 Expired
NIAID E-241-2001-0-AU-03 Development of a Preventive Vaccine for Filovirus Infection in Primates AU National Stage 2002327049 Expired
NIAID E-241-2001-1-BE-06 Development of a Preventive Vaccine for Filovirus Infection in Primates BE EP 05013732.2 Expired
NIAID E-241-2001-1-NL-14 Development of a Preventive Vaccine for Filovirus Infection in Primates NL EP 05013732.2 Expired
NIAID E-241-2001-1-DE-08 Development of a Preventive Vaccine for Filovirus Infection in Primates DE EP 05013732.2 Expired
NIAID E-241-2001-1-FR-10 Development of a Preventive Vaccine for Filovirus Infection in Primates FR EP 05013732.2 Expired
NIAID E-241-2001-1-EP-02 Development of a Preventive Vaccine for Filovirus Infection in Primates EP DIV 05013732.2 Expired
NIAID E-241-2001-1-GB-11 Development of a Preventive Vaccine for Filovirus Infection in Primates GB EP 05013732.2 Expired
NIAID E-241-2001-1-IT-13 Development of a Preventive Vaccine for Filovirus Infection in Primates IT EP 05013732.2 Expired
NIAID E-241-2001-1-IE-12 Development of a Preventive Vaccine for Filovirus Infection in Primates IE EP 05013732.2 Expired